Premium
Guanfacine to control ADHD in children and adolescents
Author(s) -
Chaplin Steve
Publication year - 2016
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1481
Subject(s) - guanfacine , medicine , attention deficit hyperactivity disorder , psychiatry , agonist , anesthesia , clonidine , receptor
Guanfacine (Intuniv) is an alpha 2A agonist indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents for whom stimulants are not appropriate. This article discusses the indications, monitoring requirements and clinical trial results.